Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review

R Sarkar, S Banerjee, SA Amin, N Adhikari… - European journal of …, 2020 - Elsevier
Abstract Among different Histone deacetylases (HDACs), histone deacetylase 3 (HDAC3) is
an epigenetic drug target which is currently marked as a potential therapeutic strategy to …

Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy

N Adhikari, T Jha, B Ghosh - Journal of Medicinal Chemistry, 2021 - ACS Publications
The acetylation of histone and non-histone proteins has been implicated in several disease
states. Modulation of such epigenetic modifications has therefore made histone …

Overview of class I HDAC modulators: Inhibitors and degraders

Z Huang, L Zeng, B Cheng, D Li - European Journal of Medicinal Chemistry, 2024 - Elsevier
Class I histone deacetylases (HDACs) are closely associated with the development of a
diverse array of diseases, including cancer, neurodegenerative disorders, HIV, and …

Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition

Z Bertels, H Singh, I Dripps, K Siegersma, AF Tipton… - Elife, 2021 - elifesciences.org
Migraine is the sixth most prevalent disease worldwide but the mechanisms that underlie
migraine chronicity are poorly understood. Cytoskeletal flexibility is fundamental to neuronal …

Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors

K Nepali, TY Chang, MJ Lai, KC Hsu, Y Yen… - European Journal of …, 2020 - Elsevier
This study reports the design, synthesis and evaluation of a series of histone deacetylase
(HDAC) inhibitors containing purine/purine isoster as a capping group and an N-(2 …

Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case–control study in Denmark, 1996–2016

A Sirirungreung, J Hansen, D He… - … and drug safety, 2023 - Wiley Online Library
Background Nitrosatable drugs can be synthesized to N‐nitroso compounds in human
stomach. In a pregnant woman, N‐nitroso compounds can be translocated to the fetus …

Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective

Z Jiang, Q You, X Zhang - European Journal of Medicinal Chemistry, 2019 - Elsevier
Numerous metal-containing enzymes (metalloenzymes) have been considered as drug
targets related to diseases such as cancers, diabetes, anemia, AIDS, malaria, bacterial …

Pharmacoepigenetic processors: epigenetic drugs, drug resistance, toxicoepigenetics, and nutriepigenetics

R Cacabelos, JC Carril, A Sanmartín, P Cacabelos - Pharmacoepigenetics, 2019 - Elsevier
The pharmacoepigenetic apparatus is integrated by gene clusters of different categories,
including (i) pathogenic genes involved in disease pathogenesis,(ii) mechanistic genes …

Two-way homologation of aliphatic aldehydes: Both one-carbon shortening and lengthening via the same intermediate

JW Yoo, Y Seo, JB Park, YG Kim - Tetrahedron, 2020 - Elsevier
Aliphatic aldehydes can be homologated to both one-carbon shorter and one-carbon longer
homologous carbonyl compounds through the 2–4 steps of reactions via the same …

Neuronal complexity is attenuated in chronic migraine and restored by HDAC6 inhibition

Z Bertels, H Singh, I Dripps, K Siegersma, AF Tipton… - bioRxiv, 2020 - biorxiv.org
Migraine is the third most prevalent disease worldwide but the mechanisms that underlie
migraine chronicity are poorly understood. Cytoskeletal flexibility is fundamental to neuronal …